奥美医疗
(002950)
| 流通市值：34.46亿 | | | 总市值：50.79亿 |
| 流通股本：4.30亿 | | | 总股本：6.33亿 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 2,882,248,274.64 | 1,838,536,273.96 | 896,090,731.55 | 3,671,573,075.99 |
| 营业收入 | 2,882,248,274.64 | 1,838,536,273.96 | 896,090,731.55 | 3,671,573,075.99 |
| 二、营业总成本 | 2,528,345,423.12 | 1,615,548,307.43 | 774,307,960.81 | 3,139,508,558.37 |
| 营业成本 | 1,997,924,408.57 | 1,264,997,586.54 | 603,315,715.6 | 2,621,161,322.52 |
| 税金及附加 | 25,284,053.33 | 17,245,305.34 | 9,583,996.47 | 31,378,739.2 |
| 销售费用 | 115,590,061.78 | 76,381,543.53 | 37,918,908.53 | 110,011,889.47 |
| 管理费用 | 224,571,343.21 | 143,755,396.27 | 71,198,405.84 | 258,369,140.72 |
| 研发费用 | 91,002,449.24 | 61,231,126.65 | 28,289,742.76 | 104,051,319.82 |
| 财务费用 | 73,973,106.99 | 51,937,349.1 | 24,001,191.61 | 14,536,146.64 |
| 其中:利息费用 | 17,790,627.35 | 10,345,469.18 | 4,569,880.8 | 17,669,454.94 |
| 其中:利息收入 | 7,425,777.37 | 4,751,568.62 | 4,060,266.79 | 16,667,208.98 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -3,130,407.93 | -7,321,753.7 | -8,014,721.06 | 7,068,508.01 |
| 加:投资收益 | 24,169,179.38 | 24,258,093.46 | 4,947,812.63 | -17,103,612.44 |
| 资产处置收益 | -31,416,451.67 | -30,841,441.84 | -3,280,731.89 | 766,842.61 |
| 资产减值损失(新) | -6,597,660.65 | -771,867.45 | 841,592.33 | -247,343,001.1 |
| 信用减值损失(新) | -1,588,654.91 | -487,524.07 | 191,334.15 | -4,024,925.41 |
| 其他收益 | 57,726,306.56 | 28,817,052.48 | 16,238,942.16 | 48,295,526.53 |
| 四、营业利润 | 393,065,162.3 | 236,640,525.41 | 132,706,999.06 | 319,723,855.82 |
| 加:营业外收入 | 1,825,234.74 | 1,226,141.35 | 600,424.32 | 1,348,049.22 |
| 减:营业外支出 | 7,231,263.1 | 2,099,564.3 | 1,661,722.25 | 12,056,359.02 |
| 五、利润总额 | 387,659,133.94 | 235,767,102.46 | 131,645,701.13 | 309,015,546.02 |
| 减:所得税费用 | 48,839,238.44 | 30,677,891.44 | 18,359,307.52 | 51,869,478.84 |
| 六、净利润 | 338,819,895.5 | 205,089,211.02 | 113,286,393.61 | 257,146,067.18 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 338,819,895.5 | 205,089,211.02 | 113,286,393.61 | 257,146,067.18 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 321,214,064.31 | 193,520,160.53 | 108,951,039.12 | 248,884,076.74 |
| 少数股东损益 | 17,605,831.19 | 11,569,050.49 | 4,335,354.49 | 8,261,990.44 |
| 扣除非经常损益后的净利润 | 291,822,124.12 | 190,589,341.45 | 105,010,486.04 | 213,783,473.93 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.52 | 0.31 | 0.18 | 0.4 |
| (二)稀释每股收益 | 0.52 | 0.31 | 0.18 | 0.4 |
| 八、其他综合收益 | -5,088,298.4 | -5,548,921.33 | -6,489,607.78 | -2,601,690.95 |
| 归属于母公司股东的其他综合收益 | -5,088,298.4 | -5,548,921.33 | -6,489,607.78 | -2,601,690.95 |
| 九、综合收益总额 | 333,731,597.1 | 199,540,289.69 | 106,796,785.83 | 254,544,376.23 |
| 归属于母公司股东的综合收益总额 | 316,125,765.91 | 187,971,239.2 | 102,461,431.34 | 246,282,385.79 |
| 归属于少数股东的综合收益总额 | 17,605,831.19 | 11,569,050.49 | 4,335,354.49 | 8,261,990.44 |
| 公告日期 | 2026-10-27 | 2026-08-27 | 2026-04-28 | 2026-04-28 |
| 审计意见(境内) | | | | 标准无保留意见 |